Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.555
+0.125 (8.74%)
Mar 9, 2026, 1:30 PM EDT - Market open
Treace Medical Concepts Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 212.69 | 209.36 | 187.12 | 141.84 | 94.42 | Upgrade
|
| Revenue Growth (YoY) | 1.59% | 11.88% | 31.92% | 50.22% | 64.59% | Upgrade
|
| Cost of Revenue | 42.94 | 41.09 | 35.18 | 25.53 | 16.89 | Upgrade
|
| Gross Profit | 169.75 | 168.26 | 151.94 | 116.31 | 77.53 | Upgrade
|
| Selling, General & Admin | 203.62 | 201.26 | 187.93 | 137.57 | 83.84 | Upgrade
|
| Research & Development | 20.28 | 20.59 | 15.44 | 13.58 | 10.2 | Upgrade
|
| Operating Expenses | 223.91 | 223.95 | 203.37 | 151.15 | 94.04 | Upgrade
|
| Operating Income | -54.15 | -55.69 | -51.43 | -34.84 | -16.51 | Upgrade
|
| Interest Expense | -5.32 | -5.26 | -5.17 | -4.4 | -4.06 | Upgrade
|
| Interest & Investment Income | 2.78 | 4.88 | 6.73 | 1.31 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.43 | 0.32 | 0.34 | -0.06 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -56.27 | -55.74 | -49.53 | -37.99 | -20.55 | Upgrade
|
| Asset Writedown | - | - | - | -0.35 | - | Upgrade
|
| Other Unusual Items | -2.74 | - | - | -4.48 | - | Upgrade
|
| Pretax Income | -59 | -55.74 | -49.53 | -42.82 | -20.55 | Upgrade
|
| Net Income | -59 | -55.74 | -49.53 | -42.82 | -20.55 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.2 | Upgrade
|
| Net Income to Common | -59 | -55.74 | -49.53 | -42.82 | -20.75 | Upgrade
|
| Shares Outstanding (Basic) | 63 | 62 | 61 | 55 | 48 | Upgrade
|
| Shares Outstanding (Diluted) | 63 | 62 | 61 | 55 | 48 | Upgrade
|
| Shares Change (YoY) | 1.86% | 2.07% | 10.09% | 14.17% | 30.61% | Upgrade
|
| EPS (Basic) | -0.93 | -0.90 | -0.81 | -0.77 | -0.43 | Upgrade
|
| EPS (Diluted) | -0.93 | -0.90 | -0.81 | -0.77 | -0.43 | Upgrade
|
| Free Cash Flow | -29.49 | -48.76 | -46.03 | -45.49 | -19.9 | Upgrade
|
| Free Cash Flow Per Share | -0.47 | -0.79 | -0.76 | -0.82 | -0.41 | Upgrade
|
| Gross Margin | 79.81% | 80.37% | 81.20% | 82.00% | 82.11% | Upgrade
|
| Operating Margin | -25.46% | -26.60% | -27.48% | -24.57% | -17.49% | Upgrade
|
| Profit Margin | -27.74% | -26.63% | -26.47% | -30.19% | -21.97% | Upgrade
|
| Free Cash Flow Margin | -13.86% | -23.29% | -24.60% | -32.07% | -21.07% | Upgrade
|
| EBITDA | -44.53 | -48.27 | -46.58 | -32.71 | -15.83 | Upgrade
|
| EBITDA Margin | -20.94% | -23.06% | -24.89% | -23.06% | -16.76% | Upgrade
|
| D&A For EBITDA | 9.62 | 7.42 | 4.85 | 2.13 | 0.69 | Upgrade
|
| EBIT | -54.15 | -55.69 | -51.43 | -34.84 | -16.51 | Upgrade
|
| EBIT Margin | -25.46% | -26.60% | -27.48% | -24.57% | -17.49% | Upgrade
|
| Advertising Expenses | 6.6 | 14.8 | 16.1 | 15 | 13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.